Q1 Earnings Estimate for Senestech Issued By HC Wainwright

Senestech, Inc. (NASDAQ:SNES) – Analysts at HC Wainwright issued their Q1 2026 EPS estimates for Senestech in a note issued to investors on Friday, March 13th. HC Wainwright analyst A. Dayal anticipates that the company will earn ($0.33) per share for the quarter. The consensus estimate for Senestech’s current full-year earnings is ($10.22) per share. HC Wainwright also issued estimates for Senestech’s Q2 2026 earnings at ($0.34) EPS, Q3 2026 earnings at ($0.35) EPS, Q4 2026 earnings at ($0.34) EPS, FY2029 earnings at $0.06 EPS and FY2030 earnings at $0.31 EPS.

Senestech (NASDAQ:SNES) last issued its earnings results on Thursday, March 12th. The company reported ($0.29) EPS for the quarter, topping analysts’ consensus estimates of ($0.30) by $0.01. The company had revenue of $0.42 million for the quarter, compared to the consensus estimate of $0.78 million. Senestech had a negative net margin of 287.39% and a negative return on equity of 85.69%.

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Senestech in a research report on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold”.

Senestech Stock Performance

Senestech stock opened at $1.92 on Monday. The firm has a 50 day simple moving average of $2.07 and a 200-day simple moving average of $3.02. The stock has a market cap of $10.02 million, a price-to-earnings ratio of -0.69 and a beta of 0.14. The company has a debt-to-equity ratio of 0.01, a current ratio of 15.75 and a quick ratio of 14.73. Senestech has a 1-year low of $1.30 and a 1-year high of $6.24.

Insider Activity

In related news, major shareholder Glenbrook Capital Management acquired 34,613 shares of Senestech stock in a transaction that occurred on Thursday, February 19th. The shares were purchased at an average cost of $2.40 per share, for a total transaction of $83,071.20. Following the acquisition, the insider owned 704,211 shares in the company, valued at approximately $1,690,106.40. This represents a 5.17% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Over the last three months, insiders bought 173,954 shares of company stock worth $367,303. 5.29% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of SNES. Geode Capital Management LLC acquired a new stake in shares of Senestech during the second quarter valued at about $59,000. Jane Street Group LLC acquired a new position in shares of Senestech in the 4th quarter worth approximately $32,000. Diversify Advisory Services LLC acquired a new position in shares of Senestech in the 4th quarter worth approximately $34,000. XTX Topco Ltd purchased a new position in shares of Senestech during the 4th quarter worth approximately $54,000. Finally, Essex Investment Management Co. LLC purchased a new position in shares of Senestech during the 3rd quarter worth approximately $115,000. Hedge funds and other institutional investors own 5.19% of the company’s stock.

About Senestech

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.